Rama Shiva Lease Finance Private Limited has submitted a disclosure to BSE Limited regarding the sale of shares in Biogen Pharmachem Industries Limited . The filing was made in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The acquirer, which is not part of the promoter or promoter group of the target company, sold 4,75,00,000 shares carrying voting rights. This transaction was executed via the open market on May 18, 2026. The shares sold represent 5.26% of the company's total share capital and voting rights.

Prior to this sale, Rama Shiva Lease Finance Private Limited held 8,40,00,000 shares, which accounted for 9.31% of the total paid-up share capital. Following the sale of the 4.75 crore shares, the acquirer's remaining holding has decreased to 3,65,00,000 shares. This revised holding constitutes 4.04% of the total share capital and voting rights of Biogen Pharmachem Industries Limited.

Shareholding Details

The disclosure outlines the changes in the acquirer's shareholding pattern, detailing the number of shares held before and after the transaction. The total equity share capital of the target company remains unchanged at Rs. 90,26,03,000, divided into 90,26,03,000 equity shares of Rs. 2 each.

The acquirer confirmed that there are no shares held under encumbrance, nor are there any warrants or convertible securities that entitle the acquirer to receive additional voting rights. The total diluted share capital of the company remains at 90,26,03,000 equity shares.

Parichay Infrastructure Limited has submitted a disclosure to BSE Limited regarding a substantial acquisition of shares in Biogen Pharmachem Industries Limited . The acquisition was made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The transaction involved the purchase of 3,99,32,000 equity shares carrying voting rights. This quantity represents 4.42% of the target company's total share capital and total diluted share capital. The mode of acquisition was reported as the open market, with the transaction settling on May 18, 2026.

Holding Details

Prior to this acquisition, Parichay Infrastructure held 8,20,00,000 shares, which accounted for 9.08% of the total share capital. The recent purchase has altered the acquirer's position in the company. The disclosure confirms that the acquirer does not belong to the promoter or promoter group of the target entity.

Post-Acquisition Status

Following the acquisition of shares on May 18, 2026, the total shareholding of Parichay Infrastructure in Biogen Pharmachem Industries Limited has adjusted to 4,20,68,000 shares. This revised holding constitutes 4.66% of the total voting capital of the target company. The equity share capital of Biogen Pharmachem Industries Limited remains at Rs. 90,26,03,000, divided into 90,26,03,000 equity shares of Rs. 2 each.

The following table summarizes the shareholding changes:

The acquirer has confirmed that there are no shares held in the nature of encumbrance, nor are there any warrants or convertible securities that entitle the acquirer to receive additional voting rights.